Diagnostic Trials
1. Minimum
Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected
Lung Carcinoma
ClinicalTrials.gov Identifier: NCT00188279
This study is designed to help decide whether a CAT scan performed at a
very low dose of radiation (Minimum dose CT scan) is better than a Chest X-Ray
in detecting recurrence of lung cancer in the chest (after surgery).
This study is ongoing, but not recruiting participants
ON
University Health Network, Toronto
2. The Utility of FDG-PET for Radiation
Treatment in NSCLC
ClinicalTrials.gov Identifier: NCT00385164
Patients planned for radical radiation for NSCLC will undergo conventional
CT stimulation and also PET/CT scans for definition of radiation target volumes
AB
Tom Baker Cancer Center, Calgary
3. Safety Evaluation of Dexmedetomidine
for EBUS-TBNA (EBUSed)3.
ClinicalTrials.gov Identifier: NCT01381627
EBUS-TBNA
are performed under monitored anesthesia care (MAC) in the endoscopy suite at
the Centre de soins ambulatoires of the Hôpital Maisonneuve-Rosemont.
Remifentanil,
used in combined regime or as single agent proved to be effective and safe for
MAC. The investigators hypothesize that compared to the use of
remifentanil-based MAC protocol, the use of dexmedetomidine-based MAC protocol
for EBUS-TBNA will result in a lower incidence of major respiratory and
hemodynamic adverse events (bradypnea, apnea, oxygen desaturation, hypotension,
hypertension, bradycardia and tachycardia) with equivalent overall procedure
conditions.
QC
Maisonneuve-Rosemont
Hospital, Montreal